Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review - PubMed (original) (raw)
Review
Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review
Lawrence Leung et al. Br J Nutr. 2009 Dec.
Abstract
It has been estimated that up to one-third of patients with diabetes mellitus use some form of complementary and alternative medicine. Momordica charantia (bitter melon) is a popular fruit used for the treatment of diabetes and related conditions amongst the indigenous populations of Asia, South America, India and East Africa. Abundant pre-clinical studies have documented the anti-diabetic and hypoglycaemic effects of M. charantia through various postulated mechanisms. However, clinical trial data with human subjects are limited and flawed by poor study design and low statistical power. The present article reviews the clinical data regarding the anti-diabetic potentials of M. charantia and calls for better-designed clinical trials to further elucidate its possible therapeutic effects.
Similar articles
- Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
Yang SJ, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Yang SJ, et al. J Nutr Biochem. 2015 Mar;26(3):234-40. doi: 10.1016/j.jnutbio.2014.10.010. Epub 2014 Nov 22. J Nutr Biochem. 2015. PMID: 25488547 - Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY, Kan WC, Cheng TJ, Yu SH, Chang LH, Chuu JJ. Wang HY, et al. Food Chem Toxicol. 2014 Jul;69:347-56. doi: 10.1016/j.fct.2014.04.008. Epub 2014 Apr 18. Food Chem Toxicol. 2014. PMID: 24751968 - Bitter melon (Momordica charantia): a review of efficacy and safety.
Basch E, Gabardi S, Ulbricht C. Basch E, et al. Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. doi: 10.1093/ajhp/60.4.356. Am J Health Syst Pharm. 2003. PMID: 12625217 Review. - Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
Yaldız G, Sekeroglu N, Kulak M, Demirkol G. Yaldız G, et al. Nat Prod Res. 2015;29(6):543-5. doi: 10.1080/14786419.2014.949706. Epub 2014 Aug 21. Nat Prod Res. 2015. PMID: 25141891 - The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease.
Richter E, Geetha T, Burnett D, Broderick TL, Babu JR. Richter E, et al. Int J Mol Sci. 2023 Feb 28;24(5):4643. doi: 10.3390/ijms24054643. Int J Mol Sci. 2023. PMID: 36902074 Free PMC article. Review.
Cited by
- Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs.
Wang Z, Wang J, Chan P. Wang Z, et al. Evid Based Complement Alternat Med. 2013;2013:343594. doi: 10.1155/2013/343594. Epub 2013 May 7. Evid Based Complement Alternat Med. 2013. PMID: 23737828 Free PMC article. - Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type II Diabetes-Mimicking Mice.
Baek HJ, Jeong YJ, Kwon JE, Ra JS, Lee SR, Kang SC. Baek HJ, et al. Evid Based Complement Alternat Med. 2018 Oct 2;2018:3468040. doi: 10.1155/2018/3468040. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30386403 Free PMC article. - Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
Hintzpeter J, Stapelfeld C, Loerz C, Martin HJ, Maser E. Hintzpeter J, et al. PLoS One. 2014 Jan 3;9(1):e84468. doi: 10.1371/journal.pone.0084468. eCollection 2014. PLoS One. 2014. PMID: 24404164 Free PMC article. - The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysis.
Yin RV, Lee NC, Hirpara H, Phung OJ. Yin RV, et al. Nutr Diabetes. 2014 Dec 15;4(12):e145. doi: 10.1038/nutd.2014.42. Nutr Diabetes. 2014. PMID: 25504465 Free PMC article. - Indicators of Accurate Health Information on the Internet on the Use of Momordica Charantia in Diabetes Mellitus.
Hernandez DP, Isip-Tan IT. Hernandez DP, et al. J ASEAN Fed Endocr Soc. 2017;32(1):14-19. doi: 10.15605/jafes.032.01.03. Epub 2017 Apr 11. J ASEAN Fed Endocr Soc. 2017. PMID: 33442079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical